Uptake and incorporation of amino acids by cultured mouse embryos: estrogen stimulation

High levels estradiol affect blastocyst implantation and post-implantation development directly in mice

Background

Previous studies have demonstrated that high levels of estradiol (E2) impair blastocyst implantation through effects on the endometrium; however, whether high E2 directly affects blastocysts is not well established. The present study sought to clarify the direct impacts of high E2 levels on blastocysts in vitro.

Methods

ICR virgin albino mice were used. Using an in-vitro 8-day blastocyst culture model, immunofluorescence staining for the estrogen receptor (ER), blastocyst outgrowth assays, differential staining and TUNEL assays of blastocysts, and embryo transfer, we investigated the main outcomes of exposure to different E2 concentrations (10⁻⁷ to 10⁻⁴ M) in vitro and in vivo.

Results

ERα and ERβ expression were detected in pre-implantation stage embryos. In vitro exposure of blastocysts to 10⁻⁴ M E2 for 24 h followed by 7 days culture in the absence of E2 caused severe inhibition of implantation and post-implantation development. The late adverse effects of E2 on post-implantation development still occurred at concentrations of 10⁻⁷ to 10⁻⁵ M. In addition, blastocyst proliferation was reduced and apoptotic cells were increased following exposure to 10⁻⁴ M E2. Using an in vivo embryo-transfer model, we also showed that treatment with high E2 resulted in fewer implantation sites (38% vs. 72% in control) and greater resorption of implanted blastocysts (81% vs. 38% in control).

Conclusion

Exposure to high E2 concentrations in vitro is deleterious to blastocyst implantation and early post-implantation development, mainly owing to direct impacts of E2 on implanting blastocysts. In clinical assisted reproductive technique (ART), high serum E2 concentrations not only affects the endometrium, but also affects blastocysts directly at the period of implantation.

Estrogen receptor and progesterone receptor genes are expressed differentially in mouse embryos during preimplantation development

Estrogen and progesterone play an important role in the development and implantation of preimplantation embryos. However, it is controversial whether these hormones act directly on the embryos. The effects of these hormones depend on the existence of their specific receptors. To determine whether estrogen receptor (ER) and progesterone receptor genes are expressed in mouse preimplantation embryos, we examined RNA from embryos at different stages of preimplantation development by reverse transcription-polymerase chain reaction techniques. ER mRNA was found in oocytes and fertilized eggs. The message level began to decline at the two-cell stage and reached its lowest level at the five- to eight-cell stage. ER mRNA was not detectable at the morula stage but reappeared at the blastocyst stage. Progesterone receptor mRNA was not detectable until the blastocyst stage. The embryonic expression of ER and progesterone receptor genes in the blastocyst suggests a possible functional requirement for ER and progesterone receptor at this stage of development. These results provide a basis for determining the direct role of estrogen and progesterone in preimplantation embryos.

Regulation of protein synthesis in the first trimester human placenta by 17 beta-oestradiol and progesterone

Addition of 17 beta-oestradiol or progesterone to first trimester human placental explants in vitro resulted in the stimulation of protein synthesis, as seen by autofluorographic analysis of placental tissue and medium proteins. An increase in the incorporation of [35S]methionine into trichloroacetic acid-precipitable proteins was seen, following the addition of 17 beta-oestradiol. Use of aromatase inhibitor to block the synthesis of 17 beta-oestradiol inhibited the protein synthesis and while addition of cyclohexamide blocked both basal- and 17 beta-oestradiol-induced protein synthesis, actinomycin-D blocked only 17 beta-oestradiol induced protein synthesis. Double labelling of placental proteins in the presence and absence of 17 beta-oestradiol also indicated that there is a significant stimulation of protein synthesis by 17 beta-oestradiol. Based on these results it is suggested that oestradiol has a role in regulation of placental protein synthesis.

Protein synthetic requirements for the outgrowth of trophoblast cells from mouse blastocysts

Mouse blastocysts cultured under optimal conditions attach to the surface of the culture dish and subsequently give rise to outgrowths of trophoblast cells. The migration of trophoblast cells appears to be analogous to their behavior during the invasive phase of implantation in utero. In these studies, we have attempted to determine the time of synthesis and nature of the products required for trophoblast outgrowth. Fourth-day blastocysts were cultured in two different media: cNCTC, a nutrient medium supplemented with fetal calf serum, and PCMF, a simple preimplantation medium lacking amino acids and serum. Trophoblast outgrowth occurs in the former, but not in the latter, medium. Most blastocysts will give rise to outgrowths following as little as 12 hr of exposure to cNCTC at the appropriate time, even if they are subsequently placed in PCMF. Outgrowth fails to occur if blastocysts are treated with cycloheximide during the interval of exposure to cNCTC, whereas treatment with the antimetabolite after the period of culture in cNCTC does not block outgrowth. These observations are consistent with the view that protein(s) essential for trophoblast outgrowth are synthesized many hours prior to the actual event.

Evidence that "embryonic estrogen" is a factor which controls the development of the mouse preimplantation embryo

4- to 8-cell mouse PIE's (preimplantation embryos) were cultured in vitro for 48 hr in media containing various concentrations of the anti-estrogen CI-628. Graded effects of the various concentrations were observed with the highest concentration (1.5 microng/ml) being 100% effective in blocking development to the blastocyst stage. The deleterious effects of the drug were prevented to some extent by including estradiol-17beta in the medium. Our interpretation is that the effect of CI-628 was due to its anti-estrogenic properties. If this interpretation is correct, then the results support our hypothesis that the development of mouse PIE's depends upon estrogen which originates in the PIE.

Surface changes of the rat embryo before implantation

Study of the rat embryo surface under the scanning electron microscope shows the superficial structure of the pellucid membrane as a perforated network cover which does not change throughout the preimplantation period (1 to 41/2 days). Dissolution of the pellucid membrane by brief ATP treatment reveals a zygotic surface which changes from day to day. The number and length of microvilli increase with development. At the early blastula stage there is a great heterogeneity of microvilli of different size and shape as well as large membranous ruffles mainly located at one pole of the embryo. The significance of these structures may relate to the changing metabolic requirements of the developing embryo and to the invasive properties of the trophoblast.